About the Authors
- Vladimir V. Shuvaev
-
Affiliation Department of Pharmacology and Center for Translational Targeted Therapeutics and Nanomedicine of the Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
- Jingyan Han
-
Affiliation Department of Pharmacology and Center for Translational Targeted Therapeutics and Nanomedicine of the Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
- Samira Tliba
-
Affiliation Department of Pharmacology and Center for Translational Targeted Therapeutics and Nanomedicine of the Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
- Evguenia Arguiri
-
Affiliation Department of Medicine, Pulmonary, Allergy and Critical Care Division, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
- Melpo Christofidou-Solomidou
-
Affiliation Department of Medicine, Pulmonary, Allergy and Critical Care Division, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
- Servio H. Ramirez
-
Affiliation Department of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America
- Holly Dykstra
-
Affiliation Department of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America
- Yuri Persidsky
-
Affiliation Department of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America
- Dmitriy N. Atochin
-
Affiliation Cardiovascular Research Center and Cardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
- Paul L. Huang
-
Affiliation Cardiovascular Research Center and Cardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
- Vladimir R. Muzykantov
-
* E-mail: muzykant@mail.med.upenn.edu
Affiliation Department of Pharmacology and Center for Translational Targeted Therapeutics and Nanomedicine of the Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: VVS JH MCS SHR YP DNA PLH VRM. Performed the experiments: VVS JH ST EA SHR HD DNA. Analyzed the data: VVS JH MCS SHR HD YP DNA PLH VRM. Contributed reagents/materials/analysis tools: VVS JH EA SHR HD DNA. Wrote the paper: VVS SHR DNA VRM. Reviewed and corrected the manuscript: JH ST EA MCS HD YP PLH.